Clinical Trials Directory

Trials / Unknown

UnknownNCT03404869

Study of ORL-1M (D-mannose) in Patients With CDG-Ib

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
5 (estimated)
Sponsor
Orpha Labs · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study of ORL-1M in Patients With CDG-Ib

Conditions

Interventions

TypeNameDescription
DRUGORL-1M - D-mannoseOral ORL-1M

Timeline

Start date
2015-03-31
Primary completion
2019-06-01
Completion
2019-06-01
First posted
2018-01-19
Last updated
2019-01-25

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03404869. Inclusion in this directory is not an endorsement.

Study of ORL-1M (D-mannose) in Patients With CDG-Ib (NCT03404869) · Clinical Trials Directory